Position in ABBV
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$6,511,184
+$1,097,424 QoQ
Shares Held
25,875
+3.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#1,151
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL BANK - TRUST DIVISION holds $28,840,563 across 8 Drug Manufacturers - General names. ABBV ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
63,423 | $8,012,860 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
25,875 | $6,511,184 | |
| 3 | JNJ |
Johnson & Johnson
|
17,878 | $4,540,474 | |
| 4 | PFE |
Pfizer Inc
|
164,898 | $3,970,742 | |
| 5 | MRK |
Merck & Co., Inc.
|
26,128 | $3,357,448 | |
| 6 | LLY |
ELI LILLY & Co
|
1,303 | $1,562,857 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,455 | $487,176 | |
| 8 | AZN |
Astrazeneca PLC
|
2,098 | $397,822 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,511,184 | 25,875 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $5,413,760 | 24,892 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $5,506,608 | 24,100 | Shares | Sole | 2026-01-02 | |
| 2025-09-30 | $5,633,367 | 24,330 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $4,718,459 | 25,420 | Shares | Sole | 2025-07-02 | |
| 2025-03-31 | $5,065,564 | 24,177 | Shares | Sole | 2025-04-01 | |
| 2024-12-31 | $4,497,053 | 25,307 | Shares | Sole | 2025-01-02 | |
| 2024-09-30 | $4,955,364 | 25,093 | Shares | Sole | 2024-10-01 | |
| 2024-06-30 | $4,473,069 | 26,079 | Shares | Sole | 2024-07-03 | |
| 2024-03-31 | $4,751,535 | 26,093 | Shares | Sole | 2024-04-01 | |
| 2023-12-31 | $378,901 | 2,445 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $435,701 | 2,923 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $298,965 | 2,219 | Shares | Sole | 2023-07-03 | |
| 2023-03-31 | $357,466 | 2,243 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $426,973 | 2,642 | Shares | Sole | 2023-01-03 | |
| 2022-09-30 | $221,848 | 1,653 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $253,173 | 1,653 | Shares | Sole | 2022-07-01 | |
| 2022-03-31 | $267,967 | 1,653 | Shares | Sole | 2022-04-04 | |
| 2021-12-31 | $222,462 | 1,643 | Shares | Sole | 2022-01-03 | |
| 2021-09-30 | $368,698 | 3,418 | Shares | Sole | 2021-10-01 | |
| 2021-06-30 | $385,003 | 3,418 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $448,354 | 4,143 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $454,314 | 4,240 | Shares | Sole | 2021-01-05 | |
| No filing history on record for this holder in this stock. | ||||||